Bio-Gene Technology Ltd
ASX:BGT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dollar General Corp
NYSE:DG
|
US |
Bio-Gene Technology Ltd
Common Stock
Bio-Gene Technology Ltd
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Bio-Gene Technology Ltd
ASX:BGT
|
Common Stock
AU$23.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Nufarm Ltd
ASX:NUF
|
Common Stock
AU$1.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Parkway Corporate Ltd
ASX:PWN
|
Common Stock
AU$41.6m
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
|
Terragen Holdings Ltd
ASX:TGH
|
Common Stock
AU$51.3m
|
CAGR 3-Years
6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Trigg Mining Ltd
ASX:TMG
|
Common Stock
AU$32.3m
|
CAGR 3-Years
27%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
|
R
|
RLF AgTech Ltd
ASX:RLF
|
Common Stock
AU$24.4m
|
CAGR 3-Years
12%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
|
Bio-Gene Technology Ltd
Glance View
Bio-Gene Technology Ltd. is a development company enabling the next generation of novel insecticides, addressing the problems of insecticide resistance and toxicity. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-29. The Company’s principal activity is to develop and commercialize insecticide products. The company is focused on enabling novel insecticides to address the global problem of insecticide resistance and toxicity. Its novel platform technology is based on naturally occurring beta-triketones. The Company’s lead beta-triketone insecticide products include Flavocide and Qcide. Flavocide is a synthetically produced nature-identical compound. Testing of Flavocide has been undertaken and continues to be performed by both government research laboratories as well as by commercial collaborators. Qcide natural oil with high levels of tasmanone. The oil is extracted from the leaves of the Gympie Messmate, by utilizing a steam distillation process.
See Also
What is Bio-Gene Technology Ltd's Common Stock?
Common Stock
23.9m
AUD
Based on the financial report for Dec 31, 2025, Bio-Gene Technology Ltd's Common Stock amounts to 23.9m AUD.
What is Bio-Gene Technology Ltd's Common Stock growth rate?
Common Stock CAGR 5Y
10%
Over the last year, the Common Stock growth was 11%. The average annual Common Stock growth rates for Bio-Gene Technology Ltd have been 7% over the past three years , 10% over the past five years .
